| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |